β-Nicotinamide Mononucleotide Monoklonaler Antikörper
β-Nicotinamide Mononucleotide Monoklonal Antikörper für ELISA, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
chemical compound
Anwendung
ELISA, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3A1F11
Kat-Nr. : 68638-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68638-1-PBS bindet in ELISA, Indirect ELISA β-Nicotinamide Mononucleotide und zeigt Reaktivität mit chemical compound
| Getestete Reaktivität | chemical compound |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | PTG |
| Vollständiger Name | β-Nicotinamide Mononucleotide |
| Gene symbol | |
| Gene ID (NCBI) | |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Nicotinamide mononucleotide ("NMN" and "β-NMN") is a nucleotide derived from ribose, nicotinamide, nicotinamide riboside and niacin. In humans, several enzymes use NMN to generate nicotinamide adenine dinucleotide (NADH). In mice, it has been proposed that NMN is absorbed via the small intestine within 10 minutes of oral uptake and converted to nicotinamide adenine dinucleotide (NAD+) through the Slc12a8 transporter. However, this observation has been challenged, and the matter remains unsettled. Maintain cell quality and reduce cell aging with β-nicotinamide mononucleotide (β-NMN), an intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD+) (Bogan & Brenner). β-NMN is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and is converted to NAD+ by nicotinamide-nucleotide adenylyltransferase.



